CLEAR MINT, GEL TOOTHPASTE

CLEAR MINT, GEL TOOTHPASTE was reported 1097 times

CLEAR MINT, GEL TOOTHPASTE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRAIN OF CEREBRAL SUBDURAL SPACE 1 0.3333
1 VERTEBRAL LATERAL RECESS STENOSIS 6 0.3158
2 LIGAMENTUM FLAVUM HYPERTROPHY 6 0.1304
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 70 0.1048
4 IDIOPATHIC PARTIAL EPILEPSY 1 0.1000
5 OSTEOARTHROPATHY 6 0.0822
6 SERONEGATIVE ARTHRITIS 90 0.0785
7 LUPUS VULGARIS 92 0.0730
8 RESPIRATORY TRACT INFECTION BACTERIAL 26 0.0522
9 RETINITIS 88 0.0509
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 92 0.0459
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 94 0.0453
12 DISLOCATION OF VERTEBRA 99 0.0434
13 FREE FATTY ACIDS INCREASED 1 0.0303
14 HYPOAESTHESIA EYE 17 0.0288
15 SWOLLEN JOINT COUNT INCREASED 82 0.0257
16 ANDROGENS ABNORMAL 1 0.0227
17 BONE EROSION 78 0.0220
18 RHEUMATIC FEVER 90 0.0202
19 SWOLLEN JOINT COUNT 5 0.0200
20 CYTOMEGALOVIRUS SYNDROME 3 0.0182
21 GRIP STRENGTH 4 0.0175
22 ACQUIRED CYSTIC KIDNEY DISEASE 1 0.0172
23 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 9 0.0160
24 GRAFT VERSUS HOST DISEASE ORAL 1 0.0156
25 WALKING AID USER 103 0.0156
26 SPONDYLITIS 56 0.0154
27 RHEUMATOID FACTOR POSITIVE 86 0.0149
28 INFECTION IN AN IMMUNOCOMPROMISED HOST 10 0.0139
29 SPINAL FUSION SURGERY 56 0.0138
30 WOUND INFECTION 150 0.0137
31 DIAPHRAGMATIC INJURY 1 0.0135
32 DUODENAL ULCER PERFORATION 90 0.0121
33 PIRIFORMIS SYNDROME 2 0.0118
34 RESPIRATORY TRACT INFECTION VIRAL 27 0.0116
35 MUSCLE INJURY 95 0.0115
36 GRIP STRENGTH DECREASED 98 0.0111
37 BREAST CANCER STAGE III 72 0.0111
38 HELICOBACTER INFECTION 114 0.0111
39 PEMPHIGUS 132 0.0105
40 AORTIC EMBOLUS 1 0.0104
41 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 71 0.0099
42 HYPERCHOLESTEROLAEMIA 95 0.0098
43 LUPUS-LIKE SYNDROME 89 0.0098
44 JOINT DISLOCATION 100 0.0095
45 FOLLICULITIS 98 0.0093
46 EXOSTOSIS 82 0.0090
47 C-REACTIVE PROTEIN 8 0.0086
48 BODY HEIGHT ABNORMAL 1 0.0086
49 AUTOIMMUNE DISORDER 83 0.0085
50 FIBRIN D DIMER INCREASED 30 0.0084
51 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 52 0.0080
52 PERICARDITIS 132 0.0078
53 FOOT DEFORMITY 86 0.0078
54 RED BLOOD CELL SEDIMENTATION RATE INCREASED 85 0.0077
55 TOE OPERATION 6 0.0076
56 HAND DEFORMITY 99 0.0075
57 PRESCRIBED UNDERDOSE 146 0.0073
58 JOINT RANGE OF MOTION DECREASED 98 0.0073
59 X-RAY ABNORMAL 13 0.0073
60 BURN ORAL CAVITY 4 0.0069
61 HEPATIC ENZYME 1 0.0067
62 SCIATICA 101 0.0063
63 CHOLELITHIASIS OBSTRUCTIVE 1 0.0060
64 BONE ATROPHY 1 0.0059
65 FACET JOINT SYNDROME 19 0.0058
66 AEROPHAGIA 1 0.0057
67 OVERLAP SYNDROME 4 0.0057
68 DRUG TOLERANCE DECREASED 16 0.0057
69 EYELID INJURY 1 0.0057
70 INTERCOSTAL NEURALGIA 1 0.0056
71 PRESCRIBED OVERDOSE 108 0.0056
72 PORPHYRIA ACUTE 8 0.0056
73 NASAL SEPTAL OPERATION 2 0.0055
74 SYNOVITIS 95 0.0053
75 FIBROMYALGIA 127 0.0052
76 HIP ARTHROPLASTY 80 0.0052
77 WOUND 146 0.0052
78 BLOOD GROWTH HORMONE DECREASED 1 0.0050
79 PULMONARY FIBROSIS 95 0.0049
80 IRRITABLE BOWEL SYNDROME 105 0.0049
81 CIRCADIAN RHYTHM SLEEP DISORDER 4 0.0048
82 LOWER LIMB FRACTURE 92 0.0048
83 TYPE 2 DIABETES MELLITUS 160 0.0047
84 HEPATIC CIRRHOSIS 89 0.0047
85 LIVER INJURY 113 0.0046
86 GLOSSODYNIA 102 0.0046
87 DIVORCED 2 0.0045
88 LIVER FUNCTION TEST INCREASED 92 0.0043
89 CREST SYNDROME 1 0.0042
90 PERIPHERAL VENOUS DISEASE 17 0.0042
91 GINGIVAL INJURY 1 0.0041
92 CHRONIC GASTROINTESTINAL BLEEDING 1 0.0039
93 JOINT STIFFNESS 102 0.0039
94 DENTURE WEARER 1 0.0039
95 DUMPING SYNDROME 1 0.0038
96 GROWTH DISORDER 1 0.0037
97 ANTICIPATORY ANXIETY 1 0.0037
98 DISABILITY 71 0.0036
99 DENTAL PLAQUE 1 0.0036
100 BUNION OPERATION 2 0.0036
101 DAIRY INTOLERANCE 1 0.0036
102 C-REACTIVE PROTEIN INCREASED 122 0.0033
103 KNEE ARTHROPLASTY 70 0.0033
104 EPIPHYSES PREMATURE FUSION 1 0.0033
105 INFECTIVE EXACERBATION OF BRONCHIECTASIS 1 0.0033
106 OSTEOARTHRITIS 138 0.0033
107 GASTROENTERITIS ROTAVIRUS 1 0.0032
108 UPPER RESPIRATORY TRACT INFECTION 145 0.0031
109 EYE INFECTION VIRAL 1 0.0031
110 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
111 EAR INFECTION 82 0.0031
112 SYSTEMIC LUPUS ERYTHEMATOSUS 106 0.0030
113 DELIRIUM 103 0.0030
114 IMPAIRED HEALING 97 0.0030
115 DECREASED VIBRATORY SENSE 1 0.0029
116 GAIT INABILITY 98 0.0029
117 HYPOCHOLESTEROLAEMIA 1 0.0028
118 OSTEOPOROSIS 116 0.0028
119 ENDOMETRIAL ABLATION 1 0.0028
120 PSORIATIC ARTHROPATHY 113 0.0028
121 ANKLE ARTHROPLASTY 1 0.0028
122 GASTROSTOMY 4 0.0026
123 SINUS PAIN 6 0.0026
124 DEPENDENCE ON RESPIRATOR 1 0.0025
125 DISEASE RISK FACTOR 1 0.0025
126 TONSIL CANCER 2 0.0025
127 FAECES SOFT 18 0.0025
128 DRUG-INDUCED LIVER INJURY 77 0.0025
129 VERTEBRAL FORAMINAL STENOSIS 2 0.0024
130 WHEEZING 142 0.0024
131 GASTROINTESTINAL CANDIDIASIS 1 0.0024
132 BLEPHAROSPASM 15 0.0024
133 OEDEMA 129 0.0024
134 PERIORBITAL PAIN 2 0.0024
135 CYTOKINE RELEASE SYNDROME 47 0.0023
136 ROAD TRAFFIC ACCIDENT 98 0.0023
137 HOMELESS 1 0.0022
138 BANKRUPTCY 1 0.0022
139 NEUROPSYCHIATRIC SYMPTOMS 2 0.0022
140 C-REACTIVE PROTEIN ABNORMAL 14 0.0022
141 ONYCHOMADESIS 9 0.0021
142 ECZEMA ASTEATOTIC 1 0.0021
143 BLOOD CHOLESTEROL INCREASED 99 0.0021
144 ANAEMIA NEONATAL 1 0.0021
145 EXOSTOSIS OF JAW 1 0.0020
146 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 34 0.0020
147 BLOOD DISORDER 16 0.0020
148 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1 0.0020
149 OROPHARYNGEAL DISCOMFORT 18 0.0020
150 LIP DRY 18 0.0020
151 BLADDER OBSTRUCTION 1 0.0019
152 ACCIDENT AT HOME 1 0.0019
153 JOINT DESTRUCTION 3 0.0019
154 ABDOMINAL INJURY 1 0.0019
155 BONE CANCER METASTATIC 1 0.0019
156 ANTIPSYCHOTIC DRUG LEVEL DECREASED 1 0.0019
157 ONYCHOMYCOSIS 8 0.0018
158 RHINALGIA 5 0.0018
159 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0018
160 GENITAL DISCOMFORT 1 0.0018
161 LIVE BIRTH 15 0.0018
162 BONE FRAGMENTATION 1 0.0018
163 PUSTULAR PSORIASIS 6 0.0017
164 MOBILITY DECREASED 125 0.0017
165 PROGRESSIVE MULTIPLE SCLEROSIS 2 0.0017
166 BURSITIS 21 0.0017
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 83 0.0017
168 ENTERAL NUTRITION 1 0.0017
169 AORTIC CALCIFICATION 1 0.0017
170 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
171 ARTHROPATHY 92 0.0017
172 INFUSION RELATED REACTION 109 0.0016
173 FEBRILE CONVULSION 2 0.0016
174 BLOOD IRON DECREASED 19 0.0016
175 NAIL DISORDER 14 0.0016
176 HEPATOBILIARY DISEASE 1 0.0016
177 DISCOMFORT 95 0.0016
178 LIP INJURY 2 0.0015
179 GINGIVAL DISCOMFORT 1 0.0015
180 BREAST CANCER STAGE I 14 0.0015
181 HEPATIC ENZYME INCREASED 101 0.0015
182 GAMBLING DISORDER 4 0.0015
183 MUSCULOSKELETAL STIFFNESS 129 0.0015
184 STOMATITIS 89 0.0015
185 CONGENITAL HAND MALFORMATION 1 0.0015
186 AMNESIA 95 0.0015
187 TONGUE BITING 3 0.0015
188 SPINAL STENOSIS 6 0.0015
189 BREAST CANCER STAGE II 12 0.0014
190 BLISTER 81 0.0014
191 INJURY 100 0.0014
192 BORDERLINE PERSONALITY DISORDER 1 0.0014
193 ATROPHIC VULVOVAGINITIS 1 0.0014
194 GINGIVAL SWELLING 6 0.0014
195 COCCYDYNIA 2 0.0014
196 BLUNTED AFFECT 1 0.0014
197 INFUSION SITE REACTION 4 0.0013
198 MYOSITIS 12 0.0013
199 CARDIAC INFECTION 1 0.0013
200 CROUP INFECTIOUS 1 0.0013
201 SEBORRHOEIC DERMATITIS 2 0.0012
202 GASTROENTERITIS SALMONELLA 1 0.0012
203 CULTURE POSITIVE 1 0.0012
204 CYSTOCELE 1 0.0012
205 CONTRAINDICATED PRODUCT ADMINISTERED 34 0.0011
206 RESPIRATORY TRACT INFECTION 29 0.0011
207 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
208 SINUSITIS 112 0.0011
209 ESSENTIAL HYPERTENSION 2 0.0011
210 VISUAL IMPAIRMENT 134 0.0011
211 BRONCHITIS 80 0.0011
212 ADENOCARCINOMA GASTRIC 1 0.0011
213 SWELLING 100 0.0011
214 ARTHRITIS 84 0.0011
215 OEDEMA PERIPHERAL 130 0.0011
216 HYPERVIGILANCE 1 0.0010
217 ULCER HAEMORRHAGE 7 0.0010
218 EAR PAIN 20 0.0010
219 COELIAC DISEASE 10 0.0010
220 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
221 COLON ADENOMA 1 0.0010
222 PERIPHERAL SWELLING 155 0.0010
223 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
224 AUTONOMIC NEUROPATHY 1 0.0010
225 TACHYCARDIA 87 0.0010
226 MUSCULAR WEAKNESS 111 0.0010
227 GENERAL PHYSICAL HEALTH DETERIORATION 113 0.0010
228 CONTUSION 94 0.0010
229 JOINT SWELLING 117 0.0010
230 BONE DEMINERALISATION 1 0.0009
231 RHEUMATOID ARTHRITIS 107 0.0009
232 OBESITY 15 0.0009
233 ASTERIXIS 1 0.0009
234 LOOSE TOOTH 3 0.0009
235 BONE NEOPLASM 1 0.0009
236 EXPOSED BONE IN JAW 2 0.0009
237 CHAPPED LIPS 4 0.0009
238 HYPOVENTILATION 3 0.0009
239 URTICARIA 153 0.0009
240 SPINAL OSTEOARTHRITIS 8 0.0009
241 SLEEP DISORDER 64 0.0009
242 PREGNANCY AFTER POST COITAL CONTRACEPTION 2 0.0009
243 IMMUNODEFICIENCY 13 0.0009
244 CHEMICAL BURN 1 0.0009
245 PRODUCT LABEL CONFUSION 5 0.0009
246 HYPORESPONSIVE TO STIMULI 1 0.0009
247 NASOPHARYNGITIS 157 0.0009
248 DYSPEPSIA 83 0.0008
249 RASH VESICULAR 4 0.0008
250 CLOSTRIDIUM COLITIS 1 0.0008
251 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
252 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
253 HAEMATOCRIT ABNORMAL 1 0.0008
254 DENTAL CARIES 9 0.0008
255 ABDOMINAL DISCOMFORT 136 0.0008
256 BLOOD UREA DECREASED 1 0.0008
257 GENERAL SYMPTOM 6 0.0008
258 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
259 HYPERAESTHESIA TEETH 1 0.0008
260 WEIGHT INCREASED 177 0.0008
261 GLUCOSE URINE PRESENT 1 0.0008
262 HEPATIC INFECTION 1 0.0008
263 HYPOAESTHESIA 116 0.0008
264 INFECTION 112 0.0008
265 RHINOVIRUS INFECTION 3 0.0008
266 ABDOMINAL OPERATION 1 0.0008
267 ASTHMA 87 0.0008
268 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
269 DRUG CLEARANCE DECREASED 1 0.0008
270 MEMORY IMPAIRMENT 105 0.0008
271 GINGIVAL PAIN 6 0.0008
272 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
273 SKIN DISCOMFORT 2 0.0007
274 BACK INJURY 8 0.0007
275 CARBON DIOXIDE INCREASED 1 0.0007
276 CLUSTER HEADACHE 1 0.0007
277 HEAD TITUBATION 1 0.0007
278 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
279 CULTURE URINE POSITIVE 1 0.0007
280 PSORIASIS 92 0.0007
281 HYPERTONIC BLADDER 2 0.0007
282 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
283 TOOTH INJURY 3 0.0007
284 LUMBAR SPINAL STENOSIS 2 0.0007
285 ORAL CANDIDIASIS 9 0.0007
286 HAEMORRHAGIC ANAEMIA 3 0.0007
287 TOOTH DISCOLOURATION 2 0.0007
288 INTENTIONAL PRODUCT USE ISSUE 59 0.0007
289 INTERCEPTED DRUG DISPENSING ERROR 1 0.0007
290 CRANIOCEREBRAL INJURY 2 0.0007
291 ASTIGMATISM 1 0.0007
292 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
293 SPINAL DISORDER 6 0.0006
294 INTERMITTENT CLAUDICATION 1 0.0006
295 THROAT TIGHTNESS 17 0.0006
296 ANTICHOLINERGIC SYNDROME 1 0.0006
297 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
298 PORTAL VEIN THROMBOSIS 2 0.0006
299 COSTOCHONDRITIS 1 0.0006
300 CONFUSIONAL STATE 99 0.0006
301 DENTAL IMPLANTATION 1 0.0006
302 BREAST ENLARGEMENT 2 0.0006
303 HYPERTENSION 129 0.0006
304 HYPERSENSITIVITY 113 0.0006
305 ALOPECIA 118 0.0006
306 DRUG INTOLERANCE 58 0.0006
307 BK VIRUS INFECTION 2 0.0006
308 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
309 FAILURE TO THRIVE 3 0.0006
310 BLOOD LACTIC ACID INCREASED 3 0.0006
311 GAIT DISTURBANCE 109 0.0006
312 POLYARTHRITIS 3 0.0006
313 MACULOPATHY 2 0.0006
314 APPLICATION SITE DISCOMFORT 1 0.0006
315 CHEILITIS 3 0.0006
316 WEIGHT DECREASED 154 0.0006
317 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
318 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
319 TASTE DISORDER 11 0.0005
320 GRANULOCYTE COUNT DECREASED 1 0.0005
321 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
322 BONE DENSITY ABNORMAL 2 0.0005
323 SNORING 2 0.0005
324 NIGHT SWEATS 17 0.0005
325 CARDIAC VALVE DISEASE 3 0.0005
326 CHEST PAIN 97 0.0005
327 CLAVICLE FRACTURE 2 0.0005
328 GINGIVAL RECESSION 1 0.0005
329 OESOPHAGEAL DISORDER 2 0.0005
330 HEPATIC MASS 1 0.0005
331 METABOLIC DISORDER 3 0.0005
332 HAEMOGLOBIN DECREASED 53 0.0005
333 CONVERSION DISORDER 1 0.0005
334 EARLY SATIETY 1 0.0005
335 GALLBLADDER INJURY 1 0.0005
336 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
337 ABDOMINAL WALL HAEMATOMA 1 0.0005
338 VIRAL INFECTION 17 0.0005
339 COLOSTOMY 1 0.0005
340 RESPIRATORY ACIDOSIS 2 0.0005
341 PYREXIA 176 0.0005
342 HYPERAEMIA 1 0.0005
343 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
344 POLYDIPSIA 2 0.0005
345 DYSPNOEA EXERTIONAL 19 0.0005
346 CANDIDIASIS 2 0.0005
347 FUNGAL SKIN INFECTION 2 0.0005
348 ADRENAL INSUFFICIENCY 6 0.0005
349 EYELID PAIN 1 0.0005
350 MUSCLE SPASTICITY 6 0.0005
351 COMPULSIVE SHOPPING 1 0.0005
352 IMPULSE-CONTROL DISORDER 1 0.0005
353 SCOLIOSIS 3 0.0005
354 ANAL PRURITUS 1 0.0005
355 PRE-EXISTING CONDITION IMPROVED 3 0.0005
356 HALLUCINATIONS, MIXED 2 0.0005
357 PAIN IN EXTREMITY 140 0.0005
358 EYE CONTUSION 1 0.0005
359 FULL BLOOD COUNT ABNORMAL 5 0.0005
360 FOETAL DISTRESS SYNDROME 1 0.0005
361 TONGUE DISCOMFORT 2 0.0005
362 ANAEMIA MACROCYTIC 1 0.0005
363 INTERVERTEBRAL DISC DISORDER 2 0.0005
364 DECREASED APPETITE 108 0.0005
365 PNEUMONIA 149 0.0005
366 EPILEPSY 14 0.0005
367 PARONYCHIA 2 0.0005
368 TOOTH FRACTURE 5 0.0005
369 PHYSICAL DISABILITY 2 0.0005
370 ANXIETY 128 0.0004
371 SKIN MASS 3 0.0004
372 CHOLESTATIC LIVER INJURY 1 0.0004
373 CALCINOSIS 1 0.0004
374 SNEEZING 10 0.0004
375 DYSPHONIA 26 0.0004
376 PRODUCT TASTE ABNORMAL 6 0.0004
377 CONDITION AGGRAVATED 134 0.0004
378 HAEMATOCRIT INCREASED 1 0.0004
379 ECCHYMOSIS 3 0.0004
380 EYELID DISORDER 1 0.0004
381 NEPHROGENIC ANAEMIA 2 0.0004
382 BACK DISORDER 7 0.0004
383 BILIRUBIN CONJUGATED INCREASED 1 0.0004
384 MATERNAL EXPOSURE DURING PREGNANCY 38 0.0004
385 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
386 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
387 DERMATITIS BULLOUS 3 0.0004
388 FINGER DEFORMITY 2 0.0004
389 DRY MOUTH 33 0.0004
390 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
391 RESPIRATORY DISORDER 12 0.0004
392 DEPRESSION 91 0.0004
393 HYPERPARATHYROIDISM SECONDARY 1 0.0004
394 ECONOMIC PROBLEM 6 0.0004
395 DRUG TOLERANCE 2 0.0004
396 PATHOLOGICAL FRACTURE 2 0.0004
397 ANGLE CLOSURE GLAUCOMA 1 0.0004
398 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
399 RHINORRHOEA 25 0.0004
400 BASAL CELL CARCINOMA 6 0.0004
401 LIVER DISORDER 17 0.0004
402 PRODUCT RESIDUE PRESENT 2 0.0004
403 CHONDROPATHY 1 0.0004
404 BLOOD CREATININE INCREASED 24 0.0004
405 HYDROCEPHALUS 2 0.0004
406 IMPAIRED GASTRIC EMPTYING 5 0.0004
407 CLUMSINESS 1 0.0004
408 FAECALOMA 2 0.0004
409 NONSPECIFIC REACTION 2 0.0004
410 ILL-DEFINED DISORDER 22 0.0004
411 GASTRIC ULCER HAEMORRHAGE 2 0.0004
412 ORAL DISCOMFORT 5 0.0004
413 VOMITING 169 0.0004
414 TREATMENT FAILURE 29 0.0003
415 HYPERTONIA 2 0.0003
416 HEART VALVE INCOMPETENCE 1 0.0003
417 THROMBOCYTOPENIA 39 0.0003
418 EXERCISE TOLERANCE DECREASED 2 0.0003
419 FIBULA FRACTURE 1 0.0003
420 ADENOVIRUS INFECTION 1 0.0003
421 HAEMOTHORAX 1 0.0003
422 BILIARY COLIC 1 0.0003
423 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
424 BRADYKINESIA 2 0.0003
425 ADVERSE EVENT 31 0.0003
426 CREPITATIONS 1 0.0003
427 BLOOD CULTURE POSITIVE 1 0.0003
428 CHEST DISCOMFORT 34 0.0003
429 BLOOD PRESSURE DECREASED 22 0.0003
430 BONE MARROW DISORDER 1 0.0003
431 EYE INJURY 1 0.0003
432 LUNG DISORDER 16 0.0003
433 PULMONARY EMBOLISM 31 0.0003
434 CHOLANGITIS 2 0.0003
435 FOREIGN BODY IN THROAT 1 0.0003
436 PRURITUS 122 0.0003
437 ABDOMINAL ADHESIONS 1 0.0003
438 BILE DUCT STONE 1 0.0003
439 HEPATITIS 8 0.0003
440 ADVERSE DRUG REACTION 28 0.0003
441 HAEMOGLOBIN ABNORMAL 2 0.0003
442 INCOHERENT 2 0.0003
443 VITAMIN D DEFICIENCY 3 0.0003
444 HAEMORRHOIDS 6 0.0003
445 PHARYNGEAL SWELLING 3 0.0003
446 DEAFNESS 8 0.0003
447 PRODUCT PREPARATION ISSUE 2 0.0003
448 TOOTH INFECTION 4 0.0003
449 PRODUCT FORMULATION ISSUE 2 0.0003
450 CORONAVIRUS INFECTION 2 0.0003
451 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
452 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
453 PREGNANCY 6 0.0003
454 CHOLECYSTITIS CHRONIC 2 0.0003
455 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
456 DIZZINESS 148 0.0003
457 ARTHRALGIA 123 0.0003
458 TOOTH ABSCESS 3 0.0003
459 SWELLING FACE 19 0.0003
460 HEPATIC FIBROSIS 1 0.0003
461 APLASIA PURE RED CELL 1 0.0003
462 BLOOD CREATININE ABNORMAL 1 0.0003
463 ENCEPHALITIS 2 0.0003
464 HAIR GROWTH ABNORMAL 2 0.0003
465 HYPERTRANSAMINASAEMIA 2 0.0003
466 PRODUCT ODOUR ABNORMAL 3 0.0003
467 MOUTH ULCERATION 6 0.0003
468 BRONCHIOLITIS 1 0.0003
469 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
470 FACIAL PARESIS 1 0.0003
471 GLOSSITIS 1 0.0003
472 DIVERTICULUM 2 0.0003
473 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
474 METASTASIS 2 0.0003
475 RASH 122 0.0003
476 DEVICE PLACEMENT ISSUE 1 0.0003
477 PAIN 171 0.0003
478 BONE LESION 1 0.0003
479 UNDERDOSE 20 0.0003
480 BLOOD PHOSPHORUS DECREASED 1 0.0003
481 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
482 MALNUTRITION 3 0.0003
483 OCULAR DISCOMFORT 3 0.0003
484 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
485 OSTEOPENIA 4 0.0003
486 PLATELET COUNT DECREASED 28 0.0003
487 SLEEP APNOEA SYNDROME 5 0.0003
488 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
489 COMMUNICATION DISORDER 1 0.0003
490 LIPASE INCREASED 2 0.0003
491 GINGIVAL DISORDER 1 0.0003
492 CONCUSSION 2 0.0003
493 CARDIOPULMONARY FAILURE 1 0.0003
494 FLUID RETENTION 13 0.0003
495 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
496 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
497 PNEUMOTHORAX 4 0.0003
498 MEDICATION ERROR 14 0.0003
499 RENAL CYST 2 0.0003
500 TRICUSPID VALVE INCOMPETENCE 2 0.0003
501 HYPERPHAGIA 1 0.0003
502 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
503 BLEPHARITIS 1 0.0002
504 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
505 FRUSTRATION TOLERANCE DECREASED 2 0.0002
506 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
507 HOMICIDAL IDEATION 1 0.0002
508 BODY TEMPERATURE INCREASED 5 0.0002
509 THERAPY NON-RESPONDER 11 0.0002
510 HYPOTENSION 49 0.0002
511 DEMYELINATION 1 0.0002
512 ARTHRITIS BACTERIAL 1 0.0002
513 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
514 TOOTH LOSS 5 0.0002
515 MIGRAINE 23 0.0002
516 HYPOKALAEMIA 11 0.0002
517 INSOMNIA 63 0.0002
518 BUNDLE BRANCH BLOCK LEFT 1 0.0002
519 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
520 AORTIC VALVE INCOMPETENCE 1 0.0002
521 INFLAMMATION 12 0.0002
522 CARDIAC MURMUR 2 0.0002
523 HORDEOLUM 1 0.0002
524 HYSTERECTOMY 2 0.0002
525 SKIN SWELLING 2 0.0002
526 BONE CANCER 1 0.0002
527 NODULE 3 0.0002
528 MUSCULOSKELETAL PAIN 12 0.0002
529 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
530 TUMOUR LYSIS SYNDROME 2 0.0002
531 OROPHARYNGEAL PAIN 21 0.0002
532 BLOOD CREATINE INCREASED 1 0.0002
533 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
534 IMPLANT SITE PAIN 1 0.0002
535 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
536 ORAL PAIN 5 0.0002
537 DIARRHOEA 144 0.0002
538 COVID-19 39 0.0002
539 WHITE BLOOD CELL COUNT DECREASED 24 0.0002
540 FATIGUE 172 0.0002
541 GINGIVAL BLEEDING 3 0.0002
542 BONE DISORDER 4 0.0002
543 END STAGE RENAL DISEASE 4 0.0002
544 HAEMOGLOBIN INCREASED 1 0.0002
545 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
546 NAUSEA 172 0.0002
547 EYE OPERATION 1 0.0002
548 PRODUCT DISTRIBUTION ISSUE 2 0.0002
549 APHONIA 3 0.0002
550 FLANK PAIN 2 0.0002
551 SQUAMOUS CELL CARCINOMA 2 0.0002
552 GASTROINTESTINAL DISORDER 19 0.0002
553 SEASONAL ALLERGY 3 0.0002
554 HYPOCALCAEMIA 4 0.0002
555 LIP SWELLING 7 0.0002
556 PRODUCT PRESCRIBING ERROR 5 0.0002
557 RECALLED PRODUCT ADMINISTERED 2 0.0002
558 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
559 NEUTROPENIA 28 0.0002
560 HEADACHE 129 0.0002
561 GASTROENTERITIS 3 0.0002
562 INFLAMMATORY BOWEL DISEASE 2 0.0002
563 NASAL CONGESTION 12 0.0002
564 FOOT OPERATION 1 0.0002
565 HAEMATOCRIT DECREASED 4 0.0002
566 HEPATIC ENZYME ABNORMAL 1 0.0002
567 PNEUMONIA ASPIRATION 5 0.0002
568 FLUID INTAKE REDUCED 1 0.0002
569 PRODUCT ADMINISTRATION ERROR 4 0.0002
570 CORONARY ARTERIAL STENT INSERTION 1 0.0002
571 DRUG LEVEL DECREASED 2 0.0002
572 NEUTROPHIL COUNT INCREASED 2 0.0002
573 TEMPERATURE INTOLERANCE 2 0.0002
574 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
575 EXPOSURE DURING PREGNANCY 12 0.0002
576 ACUTE MYELOID LEUKAEMIA 3 0.0002
577 PULMONARY HYPERTENSION 4 0.0002
578 WEIGHT FLUCTUATION 2 0.0002
579 DYSPNOEA 107 0.0002
580 BREAST PAIN 2 0.0002
581 FOOD POISONING 1 0.0002
582 RECTAL HAEMORRHAGE 8 0.0002
583 ANAL ABSCESS 1 0.0002
584 GINGIVITIS 1 0.0002
585 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
586 SKIN LACERATION 2 0.0002
587 ASTHENOPIA 1 0.0002
588 AUTISM SPECTRUM DISORDER 1 0.0002
589 DEAFNESS UNILATERAL 1 0.0002
590 HYPERKERATOSIS 1 0.0002
591 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
592 DRUG LEVEL INCREASED 3 0.0002
593 VENTRICULAR FIBRILLATION 2 0.0002
594 HEART RATE ABNORMAL 1 0.0002
595 COLITIS ULCERATIVE 8 0.0002
596 NECK PAIN 10 0.0002
597 ANGIOPATHY 1 0.0002
598 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
599 BLOOD CALCIUM DECREASED 2 0.0002
600 CHOLECYSTITIS ACUTE 1 0.0002
601 RED BLOOD CELL COUNT DECREASED 5 0.0002
602 MYOCARDITIS 2 0.0002
603 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
604 ENTEROCOLITIS 1 0.0002
605 METASTASES TO LUNG 2 0.0002
606 ANAEMIA 33 0.0002
607 HYPERVENTILATION 1 0.0002
608 ELECTROLYTE IMBALANCE 2 0.0002
609 COUGH 48 0.0002
610 HYPERTRIGLYCERIDAEMIA 1 0.0002
611 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
612 LABORATORY TEST ABNORMAL 5 0.0002
613 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
614 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
615 GALLBLADDER DISORDER 3 0.0002
616 CARDIAC PACEMAKER INSERTION 1 0.0002
617 ABDOMINAL PAIN 39 0.0002
618 GASTROENTERITIS VIRAL 3 0.0002
619 PARAESTHESIA 26 0.0002
620 PRODUCT USE ISSUE 31 0.0002
621 INGUINAL HERNIA 1 0.0002
622 ENCEPHALOPATHY 4 0.0002
623 SPINAL OPERATION 2 0.0002
624 OSTEONECROSIS OF JAW 4 0.0002
625 HEPATIC STEATOSIS 3 0.0002
626 SWOLLEN TONGUE 5 0.0002
627 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
628 DERMATITIS ALLERGIC 2 0.0002
629 BLOOD URINE PRESENT 3 0.0002
630 HYPOTHYROIDISM 5 0.0002
631 HIP FRACTURE 5 0.0002
632 ANAPHYLACTIC SHOCK 4 0.0002
633 HERPES SIMPLEX 1 0.0002
634 KIDNEY INFECTION 3 0.0002
635 MUCOSAL INFLAMMATION 4 0.0002
636 SEDATION 4 0.0002
637 ANHEDONIA 4 0.0002
638 DYSGRAPHIA 1 0.0002
639 IMMUNE SYSTEM DISORDER 2 0.0002
640 PANCREATITIS 8 0.0002
641 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
642 BLOOD PRESSURE ABNORMAL 3 0.0002
643 BRONCHIECTASIS 1 0.0001
644 COLITIS ISCHAEMIC 1 0.0001
645 FREQUENT BOWEL MOVEMENTS 4 0.0001
646 SINUS CONGESTION 2 0.0001
647 INFARCTION 1 0.0001
648 CROHN'S DISEASE 1 0.0001
649 CORONARY ARTERY OCCLUSION 2 0.0001
650 ABDOMINAL PAIN UPPER 30 0.0001
651 DEFAECATION URGENCY 1 0.0001
652 HYPOXIA 5 0.0001
653 HAND FRACTURE 1 0.0001
654 LEUKOPENIA 7 0.0001
655 SUBDURAL HAEMATOMA 2 0.0001
656 CRYING 5 0.0001
657 APATHY 2 0.0001
658 DYSSTASIA 4 0.0001
659 MUSCLE SPASMS 25 0.0001
660 PANCREATITIS ACUTE 3 0.0001
661 THERAPEUTIC RESPONSE DECREASED 8 0.0001
662 BLOOD COUNT ABNORMAL 2 0.0001
663 HEPATOCELLULAR CARCINOMA 1 0.0001
664 DIABETES MELLITUS 10 0.0001
665 FOOD ALLERGY 1 0.0001
666 HAEMOLYSIS 1 0.0001
667 CONGENITAL ANOMALY 1 0.0001
668 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
669 EJECTION FRACTION DECREASED 2 0.0001
670 TREATMENT NONCOMPLIANCE 7 0.0001
671 BONE DENSITY DECREASED 4 0.0001
672 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
673 DRUG SCREEN POSITIVE 1 0.0001
674 RESPIRATORY TRACT CONGESTION 2 0.0001
675 METASTASES TO BONE 2 0.0001
676 HEMIPLEGIA 1 0.0001
677 DRY EYE 6 0.0001
678 EOSINOPHIL COUNT INCREASED 1 0.0001
679 SURGERY 7 0.0001
680 OFF LABEL USE 104 0.0001
681 INFUSION SITE ERYTHEMA 1 0.0001
682 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
683 HYPOPHAGIA 3 0.0001
684 URINARY TRACT INFECTION 20 0.0001
685 HAEMATURIA 4 0.0001
686 DYSPHAGIA 11 0.0001
687 BLOOD MAGNESIUM DECREASED 1 0.0001
688 NIGHTMARE 4 0.0001
689 SPEECH DISORDER 6 0.0001
690 NEUROTOXICITY 2 0.0001
691 BURNING SENSATION 8 0.0001
692 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
693 METASTASES TO LIVER 2 0.0001
694 DEHYDRATION 15 0.0001
695 GOUT 2 0.0001
696 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
697 ANAL INCONTINENCE 1 0.0001
698 HEAVY MENSTRUAL BLEEDING 1 0.0001
699 TOOTHACHE 2 0.0001
700 OSTEOMYELITIS 2 0.0001
701 PNEUMONITIS 3 0.0001
702 CONSTIPATION 24 0.0001
703 PANIC ATTACK 4 0.0001
704 RESTLESSNESS 4 0.0001
705 INCREASED TENDENCY TO BRUISE 1 0.0001
706 GRAND MAL CONVULSION 1 0.0001
707 HAEMOPTYSIS 3 0.0001
708 PANCYTOPENIA 6 0.0001
709 DIARRHOEA HAEMORRHAGIC 1 0.0001
710 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
711 HYPONATRAEMIA 6 0.0001
712 EYE PAIN 6 0.0001
713 PHOTOPHOBIA 2 0.0001
714 ARTERIOSCLEROSIS 1 0.0001
715 HOT FLUSH 8 0.0001
716 INTESTINAL OBSTRUCTION 4 0.0001
717 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
718 INCREASED APPETITE 2 0.0001
719 EYE IRRITATION 6 0.0001
720 POST PROCEDURAL COMPLICATION 2 0.0001
721 HOSPITALISATION 16 0.0001
722 SEIZURE 12 0.0001
723 CHOKING 2 0.0001
724 HEPATOMEGALY 1 0.0001
725 BODY TEMPERATURE DECREASED 1 0.0001
726 HOSPICE CARE 1 0.0001
727 DISORIENTATION 4 0.0001
728 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
729 HEPATIC FAILURE 3 0.0001
730 PLEURAL EFFUSION 6 0.0001
731 DRY THROAT 1 0.0001
732 ACUTE KIDNEY INJURY 15 0.0001
733 EUPHORIC MOOD 1 0.0001
734 INITIAL INSOMNIA 1 0.0001
735 EAR DISCOMFORT 1 0.0001
736 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
737 RIB FRACTURE 2 0.0001
738 LIMB DISCOMFORT 3 0.0001
739 HYPERBILIRUBINAEMIA 1 0.0001
740 RESPIRATORY FAILURE 7 0.0001
741 ECZEMA 5 0.0001
742 HALLUCINATION, VISUAL 2 0.0001
743 NEUROPATHY PERIPHERAL 9 0.0001
744 MOOD SWINGS 3 0.0001
745 EATING DISORDER 2 0.0001
746 RETCHING 2 0.0001
747 HEREDITARY ANGIOEDEMA 1 0.0001
748 DECREASED ACTIVITY 1 0.0001
749 UNEVALUABLE EVENT 7 0.0001
750 DEEP VEIN THROMBOSIS 6 0.0001
751 RASH PRURITIC 5 0.0001
752 CHRONIC KIDNEY DISEASE 7 0.0001
753 BIPOLAR DISORDER 1 0.0001
754 SEPTIC SHOCK 4 0.0001
755 CHOLELITHIASIS 3 0.0001
756 OSTEONECROSIS 3 0.0001
757 ASPIRATION 1 0.0001
758 STAPHYLOCOCCAL INFECTION 3 0.0001
759 GASTROINTESTINAL PAIN 1 0.0001
760 BACK PAIN 21 0.0001
761 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
762 TOOTH DISORDER 2 0.0001
763 RASH PAPULAR 2 0.0001
764 FISTULA 1 0.0001
765 EYE INFECTION 1 0.0001
766 HEART RATE IRREGULAR 2 0.0001
767 FLATULENCE 5 0.0001
768 IMPAIRED DRIVING ABILITY 1 0.0001
769 DERMATITIS CONTACT 1 0.0001
770 CHOLECYSTECTOMY 1 0.0001
771 NEPHROLITHIASIS 4 0.0001
772 INJECTION SITE REACTION 6 0.0001
773 PERICARDIAL EFFUSION 2 0.0001
774 ABDOMINAL DISTENSION 9 0.0001
775 CAESAREAN SECTION 1 0.0001
776 LYMPHADENOPATHY 3 0.0001
777 MALAISE 37 0.0001
778 ATAXIA 1 0.0001
779 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
780 ACCIDENT 1 0.0001
781 RASH ERYTHEMATOUS 4 0.0001
782 MULTIPLE SCLEROSIS 4 0.0001
783 IRRITABILITY 5 0.0001
784 RENAL FAILURE 11 0.0001
785 HEPATITIS C 1 0.0001
786 SUICIDE ATTEMPT 5 0.0001
787 ATRIAL FIBRILLATION 8 0.0001
788 VERTIGO 5 0.0001
789 CYTOPENIA 1 0.0001
790 FEELING HOT 5 0.0001
791 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
792 GENERALISED OEDEMA 1 0.0001
793 ILEUS 1 0.0001
794 AGEUSIA 2 0.0001
795 HALLUCINATION 6 0.0001
796 CELLULITIS 4 0.0001
797 BRAIN OEDEMA 1 0.0001
798 COLITIS 3 0.0001
799 ERECTILE DYSFUNCTION 2 0.0001
800 ILLNESS 8 0.0001
801 SKIN ULCER 2 0.0001
802 HIATUS HERNIA 1 0.0001
803 RASH GENERALISED 2 0.0001
804 ASTHENIA 29 0.0001
805 DIPLOPIA 2 0.0001
806 DYSMENORRHOEA 1 0.0001
807 FEBRILE NEUTROPENIA 5 0.0001
808 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
809 FALL 25 0.0001
810 DYSKINESIA 3 0.0001
811 PRODUCT QUALITY ISSUE 10 0.0001
812 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
813 CARDIAC ARREST 6 0.0001
814 HAEMATOCHEZIA 4 0.0001
815 ABNORMAL DREAMS 2 0.0001
816 TREMOR 12 0.0001
817 MENTAL STATUS CHANGES 2 0.0001
818 HYPOMAGNESAEMIA 1 0.0001
819 HUNGER 1 0.0001
820 INFLUENZA 8 0.0001
821 DEVICE OCCLUSION 1 0.0001
822 BRONCHOSPASM 1 0.0001
823 HYPERSOMNIA 2 0.0001
824 CARDIOGENIC SHOCK 1 0.0001
825 SOMNOLENCE 14 0.0001
826 BALANCE DISORDER 6 0.0001
827 HYPERTHYROIDISM 1 0.0001
828 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
829 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
830 CARDIOMYOPATHY 1 0.0001
831 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
832 CATARACT 4 0.0001
833 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
834 EPISTAXIS 5 0.0001
835 APHASIA 2 0.0001
836 LACRIMATION INCREASED 2 0.0001
837 VISION BLURRED 9 0.0001
838 SUICIDAL IDEATION 6 0.0001
839 DRUG DISPENSING ERROR 1 0.0001
840 INSURANCE ISSUE 1 0.0001
841 TINNITUS 3 0.0001
842 DEVICE RELATED INFECTION 1 0.0001
843 PRODUCT DOSE OMISSION ISSUE 19 0.0001
844 FEMUR FRACTURE 2 0.0001
845 DELUSION 1 0.0001
846 NERVOUS SYSTEM DISORDER 2 0.0001
847 BRAIN FOG 1 0.0001
848 ARRHYTHMIA 3 0.0001
849 HEAD INJURY 2 0.0001
850 HALLUCINATION, AUDITORY 1 0.0001
851 INJECTION SITE BRUISING 5 0.0001
852 DRUG INEFFECTIVE 81 0.0001
853 EYE DISORDER 2 0.0001
854 VISUAL ACUITY REDUCED 2 0.0001
855 CYTOMEGALOVIRUS INFECTION 1 0.0001
856 FUNGAL INFECTION 2 0.0001
857 COMPLETED SUICIDE 5 0.0001
858 RENAL IMPAIRMENT 5 0.0001
859 HEMIPARESIS 1 0.0001
860 BLOOD PRESSURE INCREASED 9 0.0001
861 DEVICE DEFECTIVE 1 0.0001
862 NEOPLASM PROGRESSION 2 0.0001
863 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
864 HAEMORRHAGE 6 0.0001
865 RASH MACULAR 2 0.0001
866 DEVICE USE ISSUE 1 0.0001
867 INTENTIONAL PRODUCT MISUSE 5 0.0001
868 DEPRESSED MOOD 3 0.0001
869 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
870 HEAD DISCOMFORT 1 0.0001
871 CEREBRAL HAEMORRHAGE 2 0.0001
872 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
873 ACCIDENTAL OVERDOSE 2 0.0001
874 INJECTION SITE MASS 2 0.0001
875 CONJUNCTIVITIS 1 0.0001
876 BACTERIAL INFECTION 1 0.0001
877 DYSARTHRIA 2 0.0001
878 BLOOD SODIUM DECREASED 1 0.0001
879 FRACTURE 1 0.0001
880 FOOT FRACTURE 1 0.0001
881 GASTRIC ULCER 1 0.0001
882 CONVULSION 3 0.0001
883 DEATH 45 0.0001
884 ACUTE RESPIRATORY FAILURE 1 0.0001
885 HERNIA 1 0.0001
886 DYSTONIA 1 0.0001
887 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
888 BONE PAIN 3 0.0001
889 OVERDOSE 11 0.0001
890 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
891 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
892 ABNORMAL BEHAVIOUR 2 0.0001
893 COMPLICATION OF DEVICE INSERTION 1 0.0001
894 SYNCOPE 5 0.0000
895 THROMBOSIS 4 0.0000
896 EMOTIONAL DISTRESS 6 0.0000
897 DEVICE BREAKAGE 2 0.0000
898 BONE MARROW FAILURE 1 0.0000
899 CARDIO-RESPIRATORY ARREST 2 0.0000
900 DERMATITIS 1 0.0000
901 LOSS OF CONSCIOUSNESS 6 0.0000
902 HYPOACUSIS 2 0.0000
903 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
904 DRY SKIN 6 0.0000
905 NEOPLASM MALIGNANT 3 0.0000
906 HEPATOTOXICITY 1 0.0000
907 SEPSIS 5 0.0000
908 PULMONARY OEDEMA 2 0.0000
909 SKIN IRRITATION 2 0.0000
910 RENAL DISORDER 2 0.0000
911 PALPITATIONS 5 0.0000
912 OCULAR HYPERAEMIA 2 0.0000
913 PRODUCTIVE COUGH 2 0.0000
914 BLOOD GLUCOSE DECREASED 2 0.0000
915 CEREBRAL INFARCTION 1 0.0000
916 AGITATION 3 0.0000
917 INJECTION SITE URTICARIA 1 0.0000
918 DYSGEUSIA 3 0.0000
919 EXTRAPYRAMIDAL DISORDER 1 0.0000
920 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
921 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
922 ABDOMINAL PAIN LOWER 1 0.0000
923 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
924 GASTRIC CANCER 1 0.0000
925 NO ADVERSE EVENT 7 0.0000
926 HAEMATOMA 1 0.0000
927 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
928 DERMATITIS ATOPIC 2 0.0000
929 CARDIAC FAILURE CONGESTIVE 3 0.0000
930 BLOOD BILIRUBIN INCREASED 1 0.0000
931 ANAPHYLACTIC REACTION 2 0.0000
932 FEELING COLD 1 0.0000
933 DEMENTIA 1 0.0000
934 TOXICITY TO VARIOUS AGENTS 6 0.0000
935 SKIN EXFOLIATION 3 0.0000
936 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
937 CEREBROVASCULAR ACCIDENT 6 0.0000
938 INTENTIONAL DOSE OMISSION 1 0.0000
939 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
940 CHILLS 4 0.0000
941 ERYTHEMA 7 0.0000
942 ASCITES 1 0.0000
943 BLOOD POTASSIUM DECREASED 1 0.0000
944 INJECTION SITE RASH 1 0.0000
945 INTENTIONAL OVERDOSE 2 0.0000
946 HYPERHIDROSIS 4 0.0000
947 PRODUCT DOSE OMISSION 2 0.0000
948 EXPIRED PRODUCT ADMINISTERED 1 0.0000
949 INJECTION SITE PRURITUS 2 0.0000
950 EYE PRURITUS 1 0.0000
951 ANGER 1 0.0000
952 MYALGIA 5 0.0000
953 GASTRIC DISORDER 1 0.0000
954 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
955 HYPERKALAEMIA 1 0.0000
956 THERAPY INTERRUPTED 2 0.0000
957 HYPERGLYCAEMIA 1 0.0000
958 DYSURIA 1 0.0000
959 ACNE 2 0.0000
960 INJECTION SITE SWELLING 2 0.0000
961 DRUG DOSE OMISSION BY DEVICE 2 0.0000
962 DISEASE PROGRESSION 3 0.0000
963 FEELING ABNORMAL 6 0.0000
964 ABORTION SPONTANEOUS 1 0.0000
965 EXTRA DOSE ADMINISTERED 1 0.0000
966 BLINDNESS 1 0.0000
967 INFLUENZA LIKE ILLNESS 2 0.0000
968 DEVICE LEAKAGE 1 0.0000
969 DEVICE DISLOCATION 1 0.0000
970 MYOCARDIAL INFARCTION 4 0.0000
971 ANGIOEDEMA 1 0.0000
972 DEVICE ISSUE 2 0.0000
973 BREAST CANCER 2 0.0000
974 COGNITIVE DISORDER 1 0.0000
975 FLUSHING 2 0.0000
976 INJECTION SITE PAIN 6 0.0000
977 BRADYCARDIA 1 0.0000
978 DRUG DEPENDENCE 3 0.0000
979 DISTURBANCE IN ATTENTION 1 0.0000
980 HERPES ZOSTER 1 0.0000
981 INJECTION SITE ERYTHEMA 2 0.0000
982 BLOOD GLUCOSE INCREASED 3 0.0000
983 DEVICE EXPULSION 1 0.0000
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
985 INCORRECT DOSE ADMINISTERED 3 0.0000
986 DRUG INTERACTION 2 0.0000
987 CARDIAC FAILURE 1 0.0000
988 DRUG DOSE OMISSION 2 0.0000
989 DRUG WITHDRAWAL SYNDROME 1 0.0000
990 CARDIAC DISORDER 1 0.0000
991 HEART RATE INCREASED 1 0.0000